IP Library Granted Patent US 10,000,524
Granted Patent B2
US 10,000,524 · App. 14/578,137 · Granted Jun 19, 2018

Synthesis of estetrol via estrone derived steroids

Inventors: Mark Theodoor Verhaar (Groningen, NL); Thomas Koch (Groningen, NL); Erwin Gerardus Jacobus Warmerdam (Weert, NL)
Assignee: Donesta Bioscience B.V.
C07J1/007C07J1/0059C07J1/0066C07J21/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,000,524
App. No.
14/578,137
Granted
Jun 19, 2018
Kind
B2
Abstract

A process is provided for the making of estetrol starting from a 3-A-oxy-estra-1,3,5(10),15-tetraen-17-one, wherein A is an C 1 -C 5 alkyl group, preferably a methyl group, or a C 7 -C 12 benzylic group, preferably a benzyl group. This process is particularly suitable to industry.

Claims (23)

1. A process for the preparation of estra-1,3,5(10)-trien-3,15α,16α,17β-tetraol, comprising:

(a) converting estrone into 3-A-oxy-estra-1,3,5(10),15-tetraen-17-one, wherein A is a protecting group;

(b) reducing the 17-keto group of 3-A-oxy-estra-1,3,5(10),15-tetraen-17-one to 3-A-oxy-estra-1,3,5(10),15-tetraen-17β-ol;

(c) protecting the 17-OH group of 3-A-oxy-estra-1,3,5(10),15-tetraen-17β-ol to 3-A-oxy-17-Cp-oxy-estra-1,3,5(10),15-tetraene, wherein Cp is a protecting group;

(d) oxidizing the carbon-carbon double bond of ring D of 3-A-oxy-17-Cp-oxy-estra-1,3,5(10), 15-tetraene to protected estetrol; and

(e) removing the protecting groups;

wherein the protecting group A is selected from an C 1 -C 5 alkyl group or a C 7 -C 12 benzylic group and the protecting group Cp is selected from the group consisting of C 1 -C 5 carboxylates.

2. The process according to claim 1 , wherein the protecting group A is a C 7 -C 12 benzylic group.

3. The process according to claim 1 , wherein the the protecting group Cp is acetyl.

4. The process according to claim 1 , wherein the reduction of the carbonyl group is carried out using a reducing agent selected from the group of metal hydride compounds.

5. The process according to claim 4 , wherein the metal hydride compound is selected from the group consisting of LiAlH 4 , NaBH 4 , NaBH(OAc) 3 , ZnBH 4 , and NaBH 4 /CeCl 3 .

6. The process according to claim 5 , wherein the metal hydride compound is NaBH 4 in combination with CeCl 3 hydrate.

7. The process according to claim 1 , wherein the oxidation of the carbon-carbon double bond in ring D is carried out with an oxidizing agent comprising osmium tetroxide.

8. The process according to claim 7 , wherein the oxidizing agent is osmium tetroxide immobilized on poly-4-vinylpyridine.

9. The process according to claim 1 , wherein the oxidation of the carbon-carbon double bond in ring D is carried out with a catalytic amount of osmium tetroxide immobilized on poly-4-vinylpyridine.

10. The process according to claim 9 , wherein the osmium tetroxide immobilized on poly-4-vinylpyridine is used in combination with a co-oxidant.

11. The process according to claim 10 , wherein the co-oxidant is selected from the group consisting of trimethylamine-N-oxide, N-methyl morpholine-N-oxide or hydrogen peroxide.

12. The process according to claim 11 , wherein the co-oxidant is trimethylamine-N-oxide.

13. The process according to claim 1 , wherein the protective C 7 -C 12 benzylic group is removed by catalytic hydrogenation conditions.

14. The process according to claim 13 , wherein the catalytic hydrogenation conditions comprise a hydrogenation reaction using Pd on activated carbon under a hydrogen atmosphere.

15. The process according to claim 1 , wherein the protective C 1 -C 5 alkyl group is removed by using BBr 3 .

16. The process according to claim 1 , wherein protecting group A is removed first to form 17-OCp protected estetrol and subsequently protecting group Cp is removed to form estetrol.

17. The process according to claim 2 , wherein the C 7 -C 12 benzylic group is a benzyl group.

Assignments (4)
NUNC PRO TUNC ASSIGNMENT Recorded Nov 22, 2024
From: MITHRA R&D SA
To: ESTETRA SRL
Reel/Frame 069372/0286 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2022
From: ESTETRA SPRL
To: MITHRA RECHERCHE ET DÉVELOPPEMENT SA
Reel/Frame 059868/0344 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2020
From: DONESTA BIOSCIENCE B.V.
To: ESTETRA SPRL
Reel/Frame 051777/0010 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2015
From: PANTARHEI BIOSCIENCE B.V.
To: DONESTA BIOSCIENCE B.V.
Reel/Frame 035632/0119 →
Priority Claims (1)
EP 02079676 · Nov 8, 2002 · regional
Continuity (2)
Continuation 10534079
Related Publication 20150105362A1 · Apr 16, 2015
Cited By (4)
US 12,390,478 US 12,427,114 US 12,458,649 US 12,458,651